540 related articles for article (PubMed ID: 24644022)
1. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
Chiche L; Jourde-Chiche N; Whalen E; Presnell S; Gersuk V; Dang K; Anguiano E; Quinn C; Burtey S; Berland Y; Kaplanski G; Harle JR; Pascual V; Chaussabel D
Arthritis Rheumatol; 2014 Jun; 66(6):1583-95. PubMed ID: 24644022
[TBL] [Abstract][Full Text] [Related]
2. Paradoxical association between blood modular interferon signatures and quality of life in patients with systemic lupus erythematosus.
Seguier J; Jouve E; Bobot M; Whalen E; Dussol B; Gentile S; Burtey S; Halfon P; Retornaz F; Chaussabel D; Chiche L; Jourde-Chiche N
Rheumatology (Oxford); 2020 Aug; 59(8):1975-1983. PubMed ID: 31776548
[TBL] [Abstract][Full Text] [Related]
3. Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.
Paradowska-Gorycka A; Wajda A; Stypinska B; Walczuk E; Rzeszotarska E; Walczyk M; Haladyj E; Romanowska-Prochnicka K; Felis-Giemza A; Lewandowska A; Olesińska M
Clin Exp Immunol; 2021 Apr; 204(1):49-63. PubMed ID: 33336388
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of interferon-alpha/beta-inducible genes and downstream effect in a phase I trial of an anti-interferon-alpha monoclonal antibody in systemic lupus erythematosus.
Yao Y; Richman L; Higgs BW; Morehouse CA; de los Reyes M; Brohawn P; Zhang J; White B; Coyle AJ; Kiener PA; Jallal B
Arthritis Rheum; 2009 Jun; 60(6):1785-96. PubMed ID: 19479852
[TBL] [Abstract][Full Text] [Related]
5. Type I interferon gene signature test-low and -high patients with systemic lupus erythematosus have distinct gene expression signatures.
Brohawn PZ; Streicher K; Higgs BW; Morehouse C; Liu H; Illei G; Ranade K
Lupus; 2019 Nov; 28(13):1524-1533. PubMed ID: 31660791
[TBL] [Abstract][Full Text] [Related]
6. Modular transcriptional repertoire analyses identify a blood neutrophil signature as a candidate biomarker for lupus nephritis.
Jourde-Chiche N; Whalen E; Gondouin B; Speake C; Gersuk V; Dussol B; Burtey S; Pascual V; Chaussabel D; Chiche L
Rheumatology (Oxford); 2017 Mar; 56(3):477-487. PubMed ID: 28031441
[TBL] [Abstract][Full Text] [Related]
7. Activation of the interferon-alpha pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease.
Kirou KA; Lee C; George S; Louca K; Peterson MG; Crow MK
Arthritis Rheum; 2005 May; 52(5):1491-503. PubMed ID: 15880830
[TBL] [Abstract][Full Text] [Related]
8. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease.
Lood C; Amisten S; Gullstrand B; Jönsen A; Allhorn M; Truedsson L; Sturfelt G; Erlinge D; Bengtsson AA
Blood; 2010 Sep; 116(11):1951-7. PubMed ID: 20538795
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α-kinoid.
Lauwerys BR; Hachulla E; Spertini F; Lazaro E; Jorgensen C; Mariette X; Haelterman E; Grouard-Vogel G; Fanget B; Dhellin O; Vandepapelière P; Houssiau FA
Arthritis Rheum; 2013 Feb; 65(2):447-56. PubMed ID: 23203821
[TBL] [Abstract][Full Text] [Related]
10. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
11. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
12. Expression of Long Interspersed Nuclear Element 1 Retroelements and Induction of Type I Interferon in Patients With Systemic Autoimmune Disease.
Mavragani CP; Sagalovskiy I; Guo Q; Nezos A; Kapsogeorgou EK; Lu P; Liang Zhou J; Kirou KA; Seshan SV; Moutsopoulos HM; Crow MK
Arthritis Rheumatol; 2016 Nov; 68(11):2686-2696. PubMed ID: 27338297
[TBL] [Abstract][Full Text] [Related]
13. Novel signatures associated with systemic lupus erythematosus clinical response to IFN-α/-ω inhibition.
Seridi L; Cesaroni M; Orillion A; Schreiter J; Chevrier M; Marciniak S; Migone TS; Stohl W; Chatham WW; Furie RA; Benson J; Jordan J
Lupus; 2021 Apr; 30(5):795-806. PubMed ID: 33626969
[TBL] [Abstract][Full Text] [Related]
14. Coordinate overexpression of interferon-alpha-induced genes in systemic lupus erythematosus.
Kirou KA; Lee C; George S; Louca K; Papagiannis IG; Peterson MG; Ly N; Woodward RN; Fry KE; Lau AY; Prentice JG; Wohlgemuth JG; Crow MK
Arthritis Rheum; 2004 Dec; 50(12):3958-67. PubMed ID: 15593221
[TBL] [Abstract][Full Text] [Related]
15. Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature.
Shobha V; Mohan A; Malini AV; Chopra P; Karunanithi P; Subramani Thulasingam S; Selvam S; Deyati A; Srivastava R; Basavanthappa S; Lemos N; Sunitha SM; Mazumder Tagore D; Anand A; Pant S; Jayaswal V; Ramarao M; Dudhgaonkar S
Lupus; 2021 Apr; 30(5):762-774. PubMed ID: 33497307
[TBL] [Abstract][Full Text] [Related]
16. Interactions among type I and type II interferon, tumor necrosis factor, and beta-estradiol in the regulation of immune response-related gene expressions in systemic lupus erythematosus.
Lee HM; Mima T; Sugino H; Aoki C; Adachi Y; Yoshio-Hoshino N; Matsubara K; Nishimoto N
Arthritis Res Ther; 2009; 11(1):R1. PubMed ID: 19121222
[TBL] [Abstract][Full Text] [Related]
17. Cell-specific type I IFN signatures in autoimmunity and viral infection: what makes the difference?
Kyogoku C; Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Häupl T; Hiepe F; Alexander T; Radbruch A; Grützkau A
PLoS One; 2013; 8(12):e83776. PubMed ID: 24391825
[TBL] [Abstract][Full Text] [Related]
18. Type I IFN signature in childhood-onset systemic lupus erythematosus: a conspiracy of DNA- and RNA-sensing receptors?
Wahadat MJ; Bodewes ILA; Maria NI; van Helden-Meeuwsen CG; van Dijk-Hummelman A; Steenwijk EC; Kamphuis S; Versnel MA
Arthritis Res Ther; 2018 Jan; 20(1):4. PubMed ID: 29321042
[TBL] [Abstract][Full Text] [Related]
19. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
[TBL] [Abstract][Full Text] [Related]
20. Modulation of Cardiometabolic Disease Markers by Type I Interferon Inhibition in Systemic Lupus Erythematosus.
Casey KA; Smith MA; Sinibaldi D; Seto NL; Playford MP; Wang X; Carlucci PM; Wang L; Illei G; Yu B; Wang S; Remaley AT; Mehta NN; Kaplan MJ; White WI
Arthritis Rheumatol; 2021 Mar; 73(3):459-471. PubMed ID: 32909675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
